Skip to main content
Caplight Logo









Romix Biosciences

Romix Biosciences

Private
Ithaca, New YorkHealthcare & Life Scienceshttps://romixbio.com/

Last Round

Pre Seed

Jul 30, 2025

Total Funding Raised

$1.34M

Company Overview

Romix Biosciences is a biotechnology company that develops an AI-enabled, full-body molecular scan platform using cell-free RNA liquid biopsy for disease profiling and drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

cell-free RNAcfRNAliquid biopsymolecular diagnosticsprecision medicinedisease profilingbiomarker discoverypatient stratificationdrug developmentbiofluid analysisAI-enabled diagnosticsmulti-omicsbiotech platformclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Romix Biosciences Comparables

Compare Romix Biosciences with similar companies based on industry and business-model similarity.

Romix Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RealSeq Biosciences
80%
Flomics Biotech
79%
GeneCentric
77%

Romix Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJul 30, 2025
AcceleratorOct 29, 2024
AcceleratorAug 1, 2024

Key People

Founding team and executive leadership

David McKellar

CTO Co-founder

Founding Team

Conor Loy

Chief Executive Officer

Executive Team

Romix Biosciences Investors

Notable investors and investment history

Romix Biosciences investors
InvestorRounds
First Star VenturesPre Seed
2048 VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2024

    $120K raised in Accelerator round.

Romix Biosciences Filings

Explore SEC and related filing metadata, where available.

Romix Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Romix Biosciences's valuation, stock price, and market status.

Is Romix Biosciences a public or private company?

Romix Biosciences is a private company.

What is the current stock price of Romix Biosciences?

Romix Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Romix Biosciences worth (valuation)?

Valuation information for Romix Biosciences is not publicly available.

Can I buy Romix Biosciences stock?

Romix Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Romix Biosciences's last funding round?

Funding round information for Romix Biosciences is not publicly available.

Who are the main investors in Romix Biosciences?

Investor information for Romix Biosciences is not publicly disclosed.

Will Romix Biosciences IPO soon?

No public IPO plans have been announced for Romix Biosciences.

How can I track Romix Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Romix Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIthaca, New York
Employee Range5
Year Founded2024
Last FundingJul 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?